Breast Cancer Clinical Trial Using pertuzumab in combination with trastuzumab and paclitaxel

- The folks at Memorial Sloan-Kettering Cancer Center are studying the effects of pertuzumab in combination with trastuzumab and paclitaxel on Breast Cancer in females ages 18 years and older. This clinical trial is slated to start January 2011 and is expected to end circa January 2014.

646-888-5426
Overall Study Contact Info
StatusName Contact Phone
RecruitingChau Dang, MD646-888-5426

This study is officially titled, "Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer."

Locations

Memorial Sloan-Kettering at Basking Ridge

Basking Ridge, New Jersey - Recruiting

Memorial Sloan-Kettering Cancer Center @ Suffolk

Commack, New York - Recruiting

Memorial Sloan Kettering Cancer Center

New York, New York - Recruiting

Memorial Sloan-Kettering at Mercy Medical Center

Rockville Centre, New York - Recruiting

Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center

Sleepy Hollow, New York - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.